Medtech
Boston Scientific is exercising its option to buy the remaining shares of Santa Rosa, Calif.-based Millipede. The original deal was entered into in January 2018, when Boston Scientific acquired $90 million shares with the option to buy the remaining $325 million, which the company did yesterday.
Researchers at the University of Wisconsin-Madison have developed a battery-free, easily implantable device, about a third the size of a penny, that helped laboratory rats lose weight.
Strategic business expert brings broad expertise at a crucial time in UV-C high-level disinfection
Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence
PEEK resin VESTAKEEPⓇ Care* from Evonik Resource Efficiency GmbH Performance Foams and Daicel-Evonik Ltd., has been adopted as a sizing jig for pedestoplasty at Ammtec Co., Ltd.
Medtronic plc today announced it has been named one of America’s Most JUST Companies in 2018, according to Forbes magazineand JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most.
The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year.
The U.S. Food and Drug Administration (FDA) has issued an approval letter for the new features and intended uses of the Planmed Verity® CBCT scanner. Planmed is very pleased to bring these exciting improvements to the U.S. market.
Many recent college graduates with science degrees wonder, “What other careers are available outside of a laboratory or research environment?” Concurrently, a large amount of mid-career and late-career professionals consider pursuing non-traditional science roles.
Medtronic is notifying customers worldwide of a voluntary field corrective action for its Puritan Bennett(TM) 980 (PB980) ventilator series. Medtronic initiated this field action on September 19, 2018.
PRESS RELEASES